Skip to main content
SpringerLink
Log in

Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The breast is a target organ for estrogens and progesterone. These hormones control several functions of the normal and abnormal mammary epithelium including cell proliferation. Most of the actions of estrogens and progesterone are mediated via specific steroid receptors, and one would expect that proliferating cells should contain estrogen receptors (ER) and/or progesterone receptors (PR). However, the correlation between receptor expression and cell proliferation is still controversial. In the present study we have examined 29 human breast cancer samples; in 17 of them we evaluated the simultaneous ER and PR localization with that of proliferating cell nuclear antigen (PCNA) and silver-stained nucleolar organizer regions (AgNORs) in a cell-by-cell study. We found that in almost 50% of the tumor biopsies examined, the cells expressing ER were significantly associated with elevated cell proliferation. In another group (38%) there were not significant differences between ER expression and cell proliferation. In only one of the samples (6%) the cells expressing ER showed lower cell proliferation. The study also revealed that in 44% of the tumors the PR expressing cells were associated with elevated cell proliferation. In a second group the PR expression was not significantly associated with cell proliferation (33% of the cases). Finally, in 22% of the samples the cells carrying PR showed lower cell proliferation. We also detected lower ER immunoreactivity in 30% of the breast cancer biopsies with one of the monoclonal antibodies against ER (antibody 1D5 directed against the A/B domain). This group of tumors was PR-negative (or very weakly positive) and had high proliferation. The presence of tumors with ‘abnormal’ ER proteins and displaying ER/PR significantly associated with elevated cell proliferation could have implications in human breast cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ciocca DR: Tumores hormonodependientes. Conceptos actuales. Medicina (Bs As) 48: 87–94, 1988

    Google Scholar 

  2. Going JJ, Anderson TJ, Battersby S, MacIntyre CCA: Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130: 193–203, 1988

    PubMed  Google Scholar 

  3. Potten CS, Watson RJ, Williams GJ: Cell proliferation in the normal human breast. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58: 163–170, 1988

    PubMed  Google Scholar 

  4. Ferenczy A, Bertrand G, Gelfand MM: Biopsy studies of the proliferation of human endometrium. Am J Obstet Gynecol 133: 859–867, 1979

    PubMed  Google Scholar 

  5. Laidlaw IJ, Clarke R, Anderson E, Owen AWMC, Potten CS, Howell A: The proliferation of normal human breast tissue in nude mice is stimulated by oestrogen and not progesterone. In: Mansel RE (ed) Recent Developments in the Study of Benign Breast Disease. Proc 4th Int Benign Breast Symposium, 1993, pp 131–142

  6. Battersby S, Anderson TJ, King RJB, McPherson K: Functional measures of cyclical changes. In: Mansel RE (ed) Recent Developments in the Study of Benign Breast Disease. Proc 4th Int Benign Breast Symposium, 1993, pp 143–148

  7. Soule HD, McGrath CM: Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett 10: 177–189, 1980

    PubMed  Google Scholar 

  8. Osborne CK, Hobbs K, Clark GM: Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584–590, 1985

    PubMed  Google Scholar 

  9. Lippman ME, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term culture. Cancer Res 36: 4610–4618, 1976

    PubMed  Google Scholar 

  10. Lippman ME, Bolan G, Monaco ME, Pinkus L, Engel E: Model systems for the study of estrogen action in tissue culture. J Steroid Biochem 7: 1045–1051, 1976

    PubMed  Google Scholar 

  11. Aitken SC, Lippman ME: Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. Cancer Res 45: 1611–1620, 1985

    PubMed  Google Scholar 

  12. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y: Proliferation, hormonal responsiveness and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res 47: 4355–4360, 1987

    PubMed  Google Scholar 

  13. Ballare C, Bravo AI, Laucella S, Sorin I, Cerdeiro R, Loza J, Sousa Martinez F, Guman N, Mordoh J: DNA synthesis in estrogen receptor-positive human breast cancer takes place preferentially in estrogen receptor negative cells. Cancer 64: 842–848, 1989

    PubMed  Google Scholar 

  14. Ballare C, Bravo AI, Sorin I, Guman N, Schiaffi JA, Yomha R, Bagnati A, Lema B, Mordoh J: The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer. Cancer 67: 1352–1358, 1991

    PubMed  Google Scholar 

  15. Sahin AA, Ro JY, Bruner JM: Morphologic assessment of tumor proliferative fraction. Cancer Bull 45: 37–43, 1993

    Google Scholar 

  16. Derenzini M, Trerè D: Importance of interphase nucleolar organizer regions in tumor pathology. Virchows Archiv B Cell Pathol 61: 1–8, 1991

    Google Scholar 

  17. Ciocca DR, Stati AO, Amprino de Castro M: Colocalization of estrogen and progesterone receptors with an estrogen regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue. Breast Cancer Res Treat 16: 243–251, 1990

    PubMed  Google Scholar 

  18. Elias JM, Margiotta M, Gaborc BS: Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-la-beled avidin-biotin (LAB) methods. Am J Clin Pathol 92: 62–67, 1989

    PubMed  Google Scholar 

  19. Millert RT, Hapke MR, Greene GL: Immunocytochemical assay for estrogen receptor with monoclonal antibody D75 3P-gamma in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody-H222. Cancer 71: 3541–3546, 1993

    PubMed  Google Scholar 

  20. Al Saati T, Clamens S, Cohen-Knafo E, Faye JC, Prats H, Coindre JM, Wafflart J, Caverivière P, Bayard F, Delsol G. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 55: 651–654, 1993

    PubMed  Google Scholar 

  21. Press MF, Greene GL: Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Endocrinology 122: 1165–1175, 1988

    PubMed  Google Scholar 

  22. Wolf HK, Dittrich KL: Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 40: 1269–1273, 1992

    PubMed  Google Scholar 

  23. Shi S-R, Key ME, Kalra KL: Antigen retrieval in formalinfixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 33: 741–748, 1991

    Google Scholar 

  24. Elledge RM, Ciocca DR, Langone GHT, McGuire WL: Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer 71: 2499–2506, 1993

    PubMed  Google Scholar 

  25. Trerè D, Farabegoli F, Cancellieri A, Ceccarelli C, Eusebi V, Derenzini M: AgNOR area in interphase nuclei of human tumors correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki67 immunostaining. J Pathol 165: 53–59, 1991

    PubMed  Google Scholar 

  26. Vargas-Roig LM, Lotfi H, Olcese JE, Lo Castro G, Ciocca DR: Effects of short-term tamoxifen administration in patients with invasive cervical carcinoma. Anticancer Res 13: 2457–2464, 1993

    PubMed  Google Scholar 

  27. Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200–206, 1993

    PubMed  Google Scholar 

  28. Ciocca DR, Vargas-Roig LM: Estrogen receptor in human nontarget tissues: biological and clinical implications. Endocrine Rev 16: 35–62, 1995

    Google Scholar 

  29. Thomas T, Thomas TJ: Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res 54: 1077–1084, 1994

    PubMed  Google Scholar 

  30. Daniel CW, Silberstein GB: Local effects of growth factors. In: Lippman ME, Dickson RB (eds) Breast Cancer: Cellular and Molecular Biology. Kluwer Academic Publishers, Norwell, MA, 1989, pp 79–92

    Google Scholar 

  31. Fernig DG, Smith JA, Rudland PS: Relationship of growth factors and differentiation in normal and neoplastic development of the mammary gland. In: Lippman ME, Dickson RB (eds) Regulatory Mechanisms in Breast Cancer: Advances in Cellular and Molecular Biology of Breast Cancer. Kluwer Academic Publishers, Boston, 1991, pp 47–78

    Google Scholar 

  32. Truss M, Beato M: Steroid hormone receptors: interactions with deoxyribonucleic acid and transcription factors. Endocrine Rev 14: 459–479, 1993

    Google Scholar 

  33. Jakesz R, Smith CA, Aitken S, Huff K, Schuette W, Shackney S, Lippman M: Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res 44: 619–625, 1984

    PubMed  Google Scholar 

  34. Silvestrini R, Daidone MG, Di Fronzo G: Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 44: 665–670, 1979

    PubMed  Google Scholar 

  35. Marchetti E, Querzoli P, Marzola A, Bagni A, Ferretti S, Fabris G, Nenci I: Assessment of proliferative rate of breast cancer by Ki67 monoclonal antibody. Mod Pathol 3: 31–35, 1990

    PubMed  Google Scholar 

  36. Campani D, Sarnelli R, Fontanini G, Martini L, Cecchetti D, De Luca F, Squartini F: Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer. Annals New York Academy of Sciences 698: 167–173, 1993

    Google Scholar 

  37. Nicholson RI, Bouzubar N, Walker KJ, McClelland R, Dixon AR, Robertson JFR, Ellis IO, Blamey RW: Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. Eur J Cancer 27: 908–913, 1991

    PubMed  Google Scholar 

  38. Kunishio K, Ohmoto T, Matsuhisa T, Maeshiro T, Furuta T, Matsumoto K: The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence. Cancer 73: 2200–2205, 1994

    PubMed  Google Scholar 

  39. Nakamura S, Takeda Y, Okabe Y, Yoshida T, Ohtake S, Kobayashi K, Kanno M, Matsuda T: Argyrophilic proteins of the nucleolar organizer region in acute leukemias and its relation to the S-phase fraction of leukemic cells. Acta Haematol 87: 6, 1992

    PubMed  Google Scholar 

  40. Dietrich DR: Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 23: 77–109, 1993

    PubMed  Google Scholar 

  41. Hall PA, Levison DA, Woods AI, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillet CE, Camplejohn R, Dover R, Wassem NH, Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285–294, 1990

    PubMed  Google Scholar 

  42. Scott RJ, Hall PA, Haldane JS, van Noorden S, Price Y, Lane DP, Wright NA: A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165: 173–178, 1991

    PubMed  Google Scholar 

  43. Aaltomaa S, Lipponen P, Syrjanen K: Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer. Anticancer Res 13: 533–538, 1993

    PubMed  Google Scholar 

  44. Peyrat JP, Bonneterre J, Vennin PH, Jammes H, Beuscart R, Hecquet B, Djiane J, Lefebvre J, Demaille A: Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors. J Steroid Biochem Molec Biol 37: 823–827, 1990

    PubMed  Google Scholar 

  45. Ullrich SJ, Anderson CW, Mercer WE, Appella E: The p53 tumor suppressor protein, a modulator of cell proliferation. J Biol Chem 267: 15259–15262, 1992

    PubMed  Google Scholar 

  46. Daniel CW, Silberstein GB, van Horn K, Strickland P, Robinson S: TGF-beta-1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization. Dev Biol 135: 20–30, 1989

    PubMed  Google Scholar 

  47. Haslam SZ: Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology 122: 464–470, 1988

    PubMed  Google Scholar 

  48. Clarke CL, Sutherland RL: Progestin regulation of cellular proliferation. Endocrine Rev 11: 96–131, 1990

    Google Scholar 

  49. Kalkhoven E, Kwakkenbos-Isbrücker L, De Laat SW, Van der Saag PT, Van der Burg B: Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol Cell Endocrinol 102: 45–52, 1994

    PubMed  Google Scholar 

  50. Vollmer G, Gerdes J, Knuppen R: Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas. Cancer Res 49: 4011–4014, 1989

    PubMed  Google Scholar 

  51. Musgrove EA, Lee CSL, Sutherland RL: Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos, and c-myc genes. Mol Cell Biol 11: 5032–5043, 1991

    PubMed  Google Scholar 

  52. Wong MSJ, Murphy LC: Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells. J Steroid Biochem Mol Biol 39: 39–44, 1991

    PubMed  Google Scholar 

  53. Musgrove EA, Hamilton JA, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL: Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13: 3577–3587, 1993

    PubMed  Google Scholar 

  54. Murphy LC, Murphy LJ, Dubik D, Bell GI, Shiu RPC: Expression of the gene encoding epidermal growth factor in human breast cancer cells. Regulation by progestins. Cancer Res 48: 4555–4560, 1988

    PubMed  Google Scholar 

  55. Murphy LC, Dotzlaw H: Regulation of transforming growth factor-alpha and transforming growth factor-beta mRNA abundance in T-47D, human breast cancer cells. Mol Endocrinol 3: 611–617, 1989

    PubMed  Google Scholar 

  56. Stampfer MR, Yaswen P: Factors influencing growth and differentiation of normal and transformed human mammary epithelial cells in culture. In: Milo GE, Casto BL, Schuler CF (eds) Transformation of Human Epithelial Cells: Molecular and Oncogenic Mechanisms. CRC Press, Boca Raton, 1992, pp 117–140

    Google Scholar 

  57. McGuire WL, Chamness GC, Fuqua SAW: Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5: 1571–1577, 1991

    Google Scholar 

  58. Sluyser M: Role of estrogen receptor variants in the development of hormone resistance in breast cancer. Clin Biochem 25: 407–414, 1992

    PubMed  Google Scholar 

  59. Pfeffer U, Fecarotta E, Castagnetta L, Vidali G: Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer lines. Cancer Res 53: 741–743, 1993

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Reproduction and Lactation, Regional Center for Scientific and Technological Research, 5500, Mendoza, Argentina

    Mariel A. Fanelli, Laura M. Vargas-Roig & Daniel R. Ciocca

  2. Provincial Hospitals of Mendoza, 5500, Mendoza, Argentina

    Francisco E. Gago, Olga Tello & Rodolfo Lucero De Angelis

Authors
  1. Mariel A. Fanelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura M. Vargas-Roig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francisco E. Gago
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olga Tello
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rodolfo Lucero De Angelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniel R. Ciocca
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fanelli, M.A., Vargas-Roig, L.M., Gago, F.E. et al. Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer. Breast Cancer Res Tr 37, 217–228 (1996). https://doi.org/10.1007/BF01806503

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806503

Key words

Search

Navigation